Siegfried Holding AG 2023 IR
The report highlights Siegfried's strong financial and operational performance in 2023, achieving net sales of CHF 1.272 billion and a core EBITDA of CHF 273.3 million. Key strategic milestones included the acquisition of a majority stake in DINAMIQS to enter the cell and gene therapy market, the opening of a new Development Center in Barcelona, and the construction of a new R&D center in Evionnaz. On sustainability, the company reduced its absolute Scope 1 and 2 carbon emissions by 32.1% since 2020 and established its full Scope 3 value chain footprint for the first time. Additionally, Siegfried maintained its inclusion in the Dow Jones Sustainability Index Europe for the third consecutive year and achieved 71% renewable electricity usage.
Company: Siegfried Holding AG
Sector: Health Care
Country: Switzerland
Year: 2023
Type: IR
Pages: 29
Siegfried Holding AG
Progress Report
The report highlights Siegfried's strong financial and operational performance in 2023, achieving net sales of CHF 1.272 billion and a core EBITDA of CHF 273.3 million. Key strategic milestones included the acquisition of a majority stake in DINAMIQS to enter the cell and gene therapy market, the opening of a new Development Center in Barcelona, and the construction of a new R&D center in Evionnaz. On sustainability, the company reduced its absolute Scope 1 and 2 carbon emissions by 32.1% since 2020 and established its full Scope 3 value chain footprint for the first time. Additionally, Siegfried maintained its inclusion in the Dow Jones Sustainability Index Europe for the third consecutive year and achieved 71% renewable electricity usage.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees